Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Super Capacity Pump

By Drug Discovery Trends Editor | November 16, 2012

Copley Scientific has launched a super capacity pump, the SCP5, to efficiently meet requirements for high flow rate dry powder inhaler (DPI) testing, in accordance with USP and Ph.Eur. methodologies. The powerful, oil lubricated SCP5 generates flow rates up to 100 L/min (the limit required for all DPI testing) under the stable, sonic flow conditions necessary for robust aerodynamic particle size distribution (APSD) measurement, when used with all the pharmacopoeial specified cascade impactors. A quiet and space-efficient option for high flow rate generation, the SCP5 incorporates a flow control valve and regulated inlets that also enable testing of other types of orally inhaled and nasal drug products (OINDPs), for maximum flexibility.

Cascade impaction is used to measure the APSD of all OINDPs. Successful analysis relies on the application of a stable controlled air flow at an appropriate rate for the product, which for low resistance DPIs can be as high as 100 L/min. Of the pharmacopoeia specified impactors routinely used, the NGI has the highest flow resistance and therefore presents the greatest challenge in terms of ensuring the sonic flow regime that underpins flow stability.

The SCP5 shares the neat bench top design and robust engineering of the existing Copley Scientific  range of high performance, low maintenance, oil-free rotary-vane vacuum pumps that, together, span  the full range of testing requirements for OINDPs. With a 420 mm by 600 mm footprint and weighing in at 70 kg  it provides an alternative to the common practice of linking up two high capacity pumps to generate sonic flow conditions through the NGI at high flow rates. Two complete sets of vacuum inlets ( one regulated, one unregulated on either side of the pump) allow optimal positioning of the pump relative to other test equipment on the laboratory bench. The vacuum is drawn by a 1.5kW oil lubricated rotary vane pump that incorporates sound and vibration insulation, resulting in exceptionally low noise levels for its size and power. Quick release hatches allow for easy internal access for routine maintenance.

Copley Scientific


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50